Australia
Clarity enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
Highlights * Clarity has entered into a Commercial Manufacturing Agreement with SpectronRx for64Cu-SAR-bisPSMA. * SpectronRx's facility in Indiana will provide on-demand commercial-scale manufacturing of both copper-64 and64Cu-SAR-bisPSMA under one roof and enables distribution to all 50 sta...
2025-06-17 21:04
3268
Ace Green Recycling and Enecell Announce Strategic Agreement to Advance Sustainable Battery Recycling in Australia
Ace to become Enecell's exclusive offtake partner for its lead battery
recycling facility inPerth
Commercial agreement is Ace's first in Australia, the world's largest lithium
producer
HOUSTON, June 16, 2025 /PRNewswire/ -- Ace Green Recycling
2025-06-16 20:00
1911
PATHOLOGICAL COMPLETE RESPONSE RECORDED IN PATIENT FROM ACCENT CANCER TRIAL
HIGHLIGHTS * A confirmed pathological complete response has been recorded in the ACCENT trial * A pathological complete response (pCR) is extremely rare in patients undergoing treatment for advanced pancreatic cancer * A pCR means that there are no signs of cancer in tissue examined by a p...
2025-06-16 19:00
1680
NUZ-001 Shows Promise in Zebrafish Model of Huntington's Disease
Highlights: * NUZ-001 and its active metabolite NUZ-001 Sulfone demonstrated significant neuroprotective effects in a zebrafish model of Huntington's disease * Treatment prevented hallmark developmental and morphological abnormalities, protected against neuronal cell death, restored delayed h...
2025-06-16 19:00
1961
SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging
Highlights * Topline data from Clarity's diagnostic Phase II trial, SABRE, showed that 64 Cu-SAR-Bombesin was safe, well tolerated and effective at detecting prostate cancer in patients with biochemical recurrence (BCR) who are negative or equivocal on standard-of-care (SOC) scans, including pr...
2025-06-13 21:01
3485
U.S. Food & Drug Administration (FDA) Approves Investigational New Drug (IND) Application for Myrio's Lead Product (PHOX2B PC-CAR T) for the Treatment of Neuroblastoma
MELBOURNE, Australia, June 13, 2025 /PRNewswire/ -- On 7 May 2025, the FDA approved an IND application enabling Myrio's lead product (PHOX2B PC-CAR T) to enter human trials. Myrio, in collaboration the leading children's hospital in Philadelphia have co-developed a Chimeric Antigen Receptor (CAR-T...
2025-06-13 19:35
2208
Dazu Rock Carvings: The Last Monument of World Grotto Art
CHONGQING, China, June 12, 2025 /PRNewswire/ -- Located in southwest China's Chongqing Municipality, the Dazu Rock Carvings have held UNESCO World Heritage status since 1999. Sprawled across 75 recognized cultural relics protection zones, the site shelters over 50,000 breathtaking statues. As one...
2025-06-12 23:29
2276
Cam Model Earned Over $3.4 Million Streaming on LiveJasmin -- 3rd Edition of International Cam Model Day Celebrates a New Era of Creator Careers
LiveJasmin marks model appreciation week and 25 years in the industry with new
opportunities to empower models onwww.cammodelday.com
2025-06-12 01:09
2057
Uzbekistan Sees Foreign Investment Growth of over 60 per cent in 2024
'New Uzbekistan: The Big Country With Big Opportunities – Reform In Action' FDI Report unveiled as Tashkent International Investment Forum Gets Underway TASHKENT, Uzbekistan, June 10, 2025 /PRNewswire/ -- Foreign investment in Uzbekistan is growing rapidly as the country saw an over 60 per cent ...
2025-06-10 17:00
2497
DISCO topline results: 64Cu-SARTATE is highly effective in detecting tumours in NET patients compared to SOC imaging. Phase III planning underway.
HIGHLIGHTS * Topline data from Clarity's diagnostic Phase II trial, DISCO, confirms that 64Cu-SARTATE is safe and highly effective compared to standard-of-care (SOC) imaging at detecting lesions in patients with neuroendocrine tumours (NETs). * DISCO compared the diagnostic performance of 64C...
2025-06-05 21:01
2744
Mérieux NutriSciences and AsureQuality Announce the Official Launch of Mérieux NutriSciences AQ (MNAQ) Joint Venture
CHICAGO and AUCKLAND, New Zealand, June 2, 2025 /PRNewswire/ -- Mérieux NutriSciences, a global leader in food safety, quality, and sustainability, and AsureQuality,New Zealand's premier food assurance provider, are pleased to announce the official launch of their joint venture,Mérieux NutriScien...
2025-06-02 05:00
2960
NEW THERAPY FOR CHILDREN WITH GROWTH HORMONE DEFICIENCY APPROVED IN AUSTRALIA
SKYTROFA® (lonapegsomatropin) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of paediatric growth hormone deficiency.[ 1] SINGAPORE, May 29, 2025 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the Austr...
2025-05-30 00:01
2405
First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT
SYDNEY, May 29, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that it has imaged the...
2025-05-29 21:04
2122
Platinum Jets Officially Launches Services and Real-Time Instant Quote Tool for Private Jet Travel
SWANAGE, England, May 27, 2025 /PRNewswire/ -- Platinum Jets, a boutique
private jet charter broker serving a global clientele of business leaders and
luxury travelers, is proud to announce the official launch of its services
along with the debut of its cutting-edgeInstant Quote feature on
2025-05-27 21:00
1904
Alma Unveils Alma IQ at Eighth Global Alma Academy in Dubrovnik
The next-generation skin analysis platform, set to redefine the aesthetic
consultation experience
CAESAREA, Israel, May 27, 2025 /PRNewswire/ -- Alma
2025-05-27 13:00
2242
Registrational Phase III AMPLIFY trial in biochemical recurrence of prostate cancer commences
SYDNEY, May 20, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that it has commenced ...
2025-05-20 21:02
2240
Klein Vision unveils production prototype of the AirCar
The AirCar will be the world's first mass-produced flying car.
BEVERLY HILLS, Calif., May 8, 2025 /PRNewswire/ -- Klein Vision
2025-05-08 15:00
2611
Rishabh Software and S4G Consulting Launch SR360 to Accelerate Digital Transformation in Australia
MELBOURNE, Australia, May 8, 2025 /PRNewswire/ -- Rishabh Software and S4G
Consulting have teamed up to introduceSR360
2025-05-08 08:30
2375
Bellroy, the popular Australian carry brand, releases much-anticipated luggage styles
The brand renowned for solving carry problems extends their expertise to travel, with two wheeled carry-on bags that are lightweight, hard-wearing and repairable in under 10 minutes. MELBOURNE, Australia, May 6, 2025 /PRNewswire/ -- Solving problems is in Bellroy's DNA. Since their origin in 201...
2025-05-07 07:10
2967
Blinq Raises $25M Series A to Reimagine the Start of Every Professional Relationship
With over 2.5 million users across 500,000 companies in 189 countries, Blinq is scaling the platform that powers first impressions - and everything after. The new funding will support global expansion, particularly acrossNorth America and Europe, and accelerate Blinq's roadmap to become the conne...
2025-05-07 06:34
2363
Week's Top Stories
Most Reposted
DBS is First Bank in Asia Pacific to Pilot Visa Intelligent Commerce for Everyday Payments
[Picked up by 319 media titles]
2026-02-16 10:00
Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show
[Picked up by 316 media titles]
2026-02-19 14:30
Little Artists Art Studio, Singapore Shines at Art Capital 2026
[Picked up by 277 media titles]
2026-02-17 19:12
Tower Capital Asia announces majority investment in V-Key - a leader in digital identity and mobile application security
[Picked up by 265 media titles]
2026-02-13 01:52
Appier Delivers Record Results Driven by Agentic AI Innovation
[Picked up by 263 media titles]
2026-02-13 17:03Most Read
eufy Raises the Bar for Home Cleaning with Omni C28, Delivering One-Pass-Clean Performance with HydroJet™ Self-Clean Roller Mop
2026-02-14 10:00
8014
Cboe Launches Nearly 24-Hour Trading in Russell 2000 Index Options
2026-02-13 07:30
7272
Appier Delivers Record Results Driven by Agentic AI Innovation
2026-02-13 17:03
6762